Gemcitabine increases systemic 5-fluorouracil exposure in advanced cancer patients.
Correale P, Cerretani D, Marsili S, Pozzessere D, Petrioli R, Messinese S, Sabatino M, Roviello F, Pinto E, Francini G, Giorgi G.
Correale P, et al. Among authors: roviello f.
Eur J Cancer. 2003 Jul;39(11):1547-51. doi: 10.1016/s0959-8049(03)00361-7.
Eur J Cancer. 2003.
PMID: 12855261
Clinical Trial.